Clinically isolated syndrome: a protected zone for trials of new therapies?

Michael Hutchinson; John Zajicek

doi:10.1177/1352458510366015

Clinically isolated syndrome: a protected zone for trials of new therapies?

Michael Hutchinson, John Zajicek

School of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	754-5
Number of pages	2
Journal	Multiple Sclerosis Journal
Volume	16
Issue number	6
DOIs	https://doi.org/10.1177/1352458510366015
Publication status	Published - Jun 2010

Keywords

Clinical Trials as Topic
Demyelinating Diseases
Humans

Access to Document

10.1177/1352458510366015

Cite this

@article{826b37c429564e61843d5015015b68cf,

title = "Clinically isolated syndrome: a protected zone for trials of new therapies?",

keywords = "Clinical Trials as Topic, Demyelinating Diseases, Humans",

author = "Michael Hutchinson and John Zajicek",

year = "2010",

month = jun,

doi = "10.1177/1352458510366015",

language = "English",

volume = "16",

pages = "754--5",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "Sage",

number = "6",

}

TY - JOUR

T1 - Clinically isolated syndrome

T2 - a protected zone for trials of new therapies?

AU - Hutchinson, Michael

AU - Zajicek, John

PY - 2010/6

Y1 - 2010/6

KW - Clinical Trials as Topic

KW - Demyelinating Diseases

KW - Humans

UR - https://www.scopus.com/pages/publications/77953732643

U2 - 10.1177/1352458510366015

DO - 10.1177/1352458510366015

M3 - Article

C2 - 20427416

SN - 1352-4585

VL - 16

SP - 754

EP - 755

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

IS - 6

ER -

Clinically isolated syndrome: a protected zone for trials of new therapies?

Keywords

Access to Document

Other files and links

Cite this